Can Self-Sampling and care navigators beat cervical cancer in kenya?

NCT ID NCT07050745

Recruiting now Knowledge-focused Sponsor: Kenyatta National Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a program called DADA-LINK to help more women in Kenya get screened for cervical cancer. The program includes HPV self-sampling kits, a care navigator to guide patients, and a phone app to track care. About 1,980 women aged 25-49 will take part, and researchers will see if the program increases screening and treatment rates.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: HPV self-sampling kit, care navigation, mHealth platform
What this could lead to: If successful, this could show a practical way to increase cervical cancer screening and follow-up in low-resource settings, potentially saving lives through earlier detection.
What could go wrong: This is an implementation study, not a test of a new treatment. Results may not apply to other regions or populations. The study is relatively small and short-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical cancer Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCER CERVICAL CANCER SCREENING HPV DNA

Contacts and locations

Locations

Kenyatta National Hospital
RECRUITING

Nairobi, Kenya

More trials for these conditions

Other studies related to the condition(s) this trial covers.